AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15850917 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 14672523 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted thoracic surgery (VATS)
Number of subjects: 0
Study 14672523 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited resection (sublobar resection, wedge resection, segmentectomy)
Number of subjects: 0
Study 14672523 — intervention group
Group type: COMPARATOR
Intervention: Conventional open thoracotomy
Number of subjects: 0
Study 10617258 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful event
Number of subjects: 43
Study 10617258 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpain event
Number of subjects: 43
Study 10617258 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline event
Number of subjects: 43
Study 10617258 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrater reliability of PIPP scores
Number of subjects: 43
Study 10617258 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarater reliability of PIPP scores
Number of subjects: 43
Study 8950881 — intervention group
Group type: EXPERIMENTAL
Intervention: MNrgp120 vaccine
Number of subjects: 573
Study 8950881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 573
Study 1768822 — intervention group
Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 89
Study 1768822 — intervention group
Group type: COMPARATOR
Intervention: Inactive TENS (Control)
Number of subjects: 89
Study 7043385 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate, 200 mg administered intramuscularly four times at three-week intervals
Number of subjects: 16
Study 7043385 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 16
Study 30714427 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine infusion of 0.5 ml platelet-rich plasma (PRP) 48 hours before blastocyst transfer
Number of subjects: 97
Study 30714427 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 97
Study 31097515 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP treatment in non-dipper patients
Number of subjects: 272
Study 31097515 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP treatment in dipper patients
Number of subjects: 272
Study 27987395 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained lung inflation (SLI at 25cmH2O for 15s)
Number of subjects: 81
Study 27987395 — intervention group
Group type: COMPARATOR
Intervention: Standard resuscitation (Non‐SLI group)
Number of subjects: 81
Study 27987395 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained lung inflation (SLI)
Number of subjects: 81
Study 25359163 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D3 (4000 IU/d)
Number of subjects: 534
Study 25359163 — intervention group
Group type: COMPARATOR
Intervention: Low-dose vitamin D3 (400 IU/d)
Number of subjects: 534
Study 23603644 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefabricated wrist splint
Number of subjects: 94
Study 23603644 — intervention group
Group type: COMPARATOR
Intervention: Short-arm cast
Number of subjects: 94
Study 21333020 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week pedometer-based graduated walking programme and physical activity consultations
Number of subjects: 0
Study 21333020 — intervention group
Group type: COMPARATOR
Intervention: 12-week waiting list control group (delayed group)
Number of subjects: 0
Study 19569065 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary nicardipine (200 mcg)
Number of subjects: 193
Study 19569065 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 193
Study 16890144 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium diet (HS) > 200 mmol Na/day
Number of subjects: 13
Study 16890144 — intervention group
Group type: COMPARATOR
Intervention: Low sodium diet (LS) < 10 mmol Na/day
Number of subjects: 13
Study 16890144 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium diet (HS) response to Ang II infusion
Number of subjects: 13
Study 16890144 — intervention group
Group type: COMPARATOR
Intervention: Low sodium diet (LS) response to Ang II infusion
Number of subjects: 13
Study 15006280 — intervention group
Group type: COMPARATOR
Intervention: Male faculty - Male resident dyad (reference comparison)
Number of subjects: 160
Study 15006280 — intervention group
Group type: COMPARATOR
Intervention: Female faculty - Male resident dyad
Number of subjects: 160
Study 15006280 — intervention group
Group type: COMPARATOR
Intervention: Male faculty - Female resident dyad
Number of subjects: 160
Study 15006280 — intervention group
Group type: COMPARATOR
Intervention: Female faculty - Female resident dyad
Number of subjects: 160
Study 11869164 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised controlled trials
Number of subjects: 2376
Study 11869164 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic reviews
Number of subjects: 2376
Study 9677796 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral mesoglycan (200 mg/day)
Number of subjects: 2
Study 9677796 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 2
Study 7926242 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin depot therapy for 2 months
Number of subjects: 55
Study 7926242 — intervention group
Group type: COMPARATOR
Intervention: Control group (proliferative phase of the cycle)
Number of subjects: 55
Study 2911851 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic drug monitoring program
Number of subjects: 0
Study 2911851 — intervention group
Group type: COMPARATOR
Intervention: Withdrawal of the therapeutic drug monitoring program
Number of subjects: 0
Study 2911851 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinstitution of the therapeutic drug monitoring program
Number of subjects: 0
Study 1110818 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction curettage
Number of subjects: 60
Study 1110818 — intervention group
Group type: COMPARATOR
Intervention: Dilatation and curettage
Number of subjects: 60
Study 6107136 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol at a dose level of 1,280‐1,920 mg per day
Number of subjects: 12
Study 6107136 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 12
Study 31748296 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted oesophagectomy (LAO)
Number of subjects: 0
Study 31748296 — intervention group
Group type: COMPARATOR
Intervention: Open oesophagectomy (OO)
Number of subjects: 0
Study 28958651 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.23% ropivacaine at 5 ml/h
Number of subjects: 99
Study 28958651 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline at 5 ml/h
Number of subjects: 99
Study 26945812 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat milk consumption (200 mL twice daily for 6 weeks)
Number of subjects: 58
Study 26945812 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintaining habitual diet)
Number of subjects: 58
Study 24215623 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (GD without TAO)
Number of subjects: 97
Study 24215623 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (GD with TAO)
Number of subjects: 97
Study 24215623 — intervention group
Group type: COMPARATOR
Intervention: Group 3 (Healthy participants)
Number of subjects: 97
Study 22385444 — intervention group
Group type: EXPERIMENTAL
Intervention: Patelloplasty (Group A)
Number of subjects: 152
Study 22385444 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment (Group B)
Number of subjects: 152
Study 22385444 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 152
Study 20923529 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich diet (>70% carbohydrate)
Number of subjects: 320
Study 20923529 — intervention group
Group type: COMPARATOR
Intervention: Control diet (<70% carbohydrate)
Number of subjects: 320
Study 17714607 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide 160 microg once daily (CIC160 OD)
Number of subjects: 111
Study 17714607 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate 250 microg twice daily (FP250 BID)
Number of subjects: 111
Study 12920059 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK octapeptide (CCK-8; 112 ng/min for 23 min) with gastric distension (300 ml)
Number of subjects: 8
Study 12920059 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion with gastric distension (300 ml)
Number of subjects: 8
Study 12920059 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK octapeptide (CCK-8; 112 ng/min for 23 min) without gastric distension
Number of subjects: 8
Study 12920059 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion without gastric distension
Number of subjects: 8
Study 12920059 — intervention group
Group type: COMPARATOR
Intervention: Gastric distension (300 ml) without CCK
Number of subjects: 8
Study 11938830 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiangsha Yangwei pill (XSYW)
Number of subjects: 60
Study 11938830 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 60
Study 11938830 — intervention group
Group type: EXPERIMENTAL
Intervention: Motilium
Number of subjects: 60
Study 11938830 — intervention group
Group type: COMPARATOR
Intervention: Spine Surgery (SpS)
Number of subjects: 60
Study 9437628 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively enhanced counseling
Number of subjects: 527
Study 9437628 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 527
Study 8265515 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 169,369 30 mg
Number of subjects: 10
Study 8265515 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 169,369 120 mg
Number of subjects: 10
Study 8265515 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2869848 — intervention group
Group type: EXPERIMENTAL
Intervention: nadolol
Number of subjects: 44
Study 2869848 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol
Number of subjects: 44
Study 28224445 — intervention group
Group type: EXPERIMENTAL
Intervention: Skills training app
Number of subjects: 186
Study 28224445 — intervention group
Group type: COMPARATOR
Intervention: Skills training app (men)
Number of subjects: 186
Study 28224445 — intervention group
Group type: COMPARATOR
Intervention: Skills training app (women)
Number of subjects: 186
Study 24933175 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential photo lineup procedure
Number of subjects: 494
Study 24933175 — intervention group
Group type: COMPARATOR
Intervention: Simultaneous photo lineup procedure
Number of subjects: 494
Study 24933175 — intervention group
Group type: EXPERIMENTAL
Intervention: Both procedures (simultaneous and sequential)
Number of subjects: 494
Study 23404735 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Treatment (HIT)
Number of subjects: 0
Study 23404735 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Treatment (LIT)
Number of subjects: 0
Study 23404735 — intervention group
Group type: COMPARATOR
Intervention: No Intervention
Number of subjects: 0
Study 21316861 — intervention group
Group type: EXPERIMENTAL
Intervention: Client statements indicating desire and reasons for change
Number of subjects: 61
Study 21316861 — intervention group
Group type: EXPERIMENTAL
Intervention: Commitment language
Number of subjects: 61
Study 19563454 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in total carbohydrate intake by 1 E%
Number of subjects: 644
Study 19563454 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in sucrose intake by 1 E%
Number of subjects: 644
Study 19131303 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecture training group
Number of subjects: 297
Study 19131303 — intervention group
Group type: EXPERIMENTAL
Intervention: Video training group
Number of subjects: 297
Study 15458799 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (cycling at 50% of peak oxygen uptake)
Number of subjects: 19
Study 15458799 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (cycling at 75% of peak oxygen uptake)
Number of subjects: 19
Study 15458799 — intervention group
Group type: COMPARATOR
Intervention: Sedentary condition
Number of subjects: 19
Study 15458799 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise
Number of subjects: 19
Study 15458799 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise
Number of subjects: 19
Study 11842709 — intervention group
Group type: EXPERIMENTAL
Intervention: Home management (acute care at home)
Number of subjects: 25
Study 11842709 — intervention group
Group type: COMPARATOR
Intervention: Hospital management
Number of subjects: 25
Study 11842709 — intervention group
Group type: EXPERIMENTAL
Intervention: Home management
Number of subjects: 25
Study 11842709 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 25
Study 9150288 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical pain stimulus
Number of subjects: 24
Study 9150288 — intervention group
Group type: COMPARATOR
Intervention: Control stimulus
Number of subjects: 24
Study 7963282 — intervention group
Group type: EXPERIMENTAL
Intervention: Remembering word-and-background pairs
Number of subjects: 0
Study 7963282 — intervention group
Group type: COMPARATOR
Intervention: Remembering words
Number of subjects: 0
Study 3307499 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fructose mineral drink
Number of subjects: 25
Study 3307499 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 25
Study 30562555 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-specific training on the functional reaching task (3 days, 150 trials)
Number of subjects: 90
Study 30562555 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional reaching training
Number of subjects: 90
Study 30562555 — intervention group
Group type: COMPARATOR
Intervention: No training
Number of subjects: 90
Study 28530532 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy for 8 weeks
Number of subjects: 60
Study 28530532 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 25761837 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (75 mg)
Number of subjects: 24
Study 25761837 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (75 mg) + L-theanine (50 mg)
Number of subjects: 24
Study 25761837 — intervention group
Group type: COMPARATOR
Intervention: L-theanine (50 mg)
Number of subjects: 24
Study 25761837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 23922133 — intervention group
Group type: EXPERIMENTAL
Intervention: Picking or nibbling (P&N) behavior in binge eating disorder (BED)
Number of subjects: 660
Study 23922133 — intervention group
Group type: EXPERIMENTAL
Intervention: Picking or nibbling (P&N) behavior in bulimia nervosa (BN)
Number of subjects: 660
Study 23922133 — intervention group
Group type: EXPERIMENTAL
Intervention: Picking or nibbling (P&N) behavior in anorexia nervosa (AN)
Number of subjects: 660
Study 23922133 — intervention group
Group type: COMPARATOR
Intervention: Association of P&N with BMI, compensatory behaviors, binge eating, or eating disorder examination subscales
Number of subjects: 660
Study 21114493 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938 at a dose of 1 × 10(8) CFU per day for 30 days
Number of subjects: 42
Study 21114493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 19168109 — intervention group
Group type: EXPERIMENTAL
Intervention: HEV 239 vaccine
Number of subjects: 612
Study 16715641 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% Knowledge of Results (KR)
Number of subjects: 16
Study 16715641 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% Knowledge of Results (KR)
Number of subjects: 16
Study 14769686 — intervention group
Group type: EXPERIMENTAL
Intervention: sirolimus‐eluting stent
Number of subjects: 1058
Study 14769686 — intervention group
Group type: COMPARATOR
Intervention: Control bare stent
Number of subjects: 1058
Study 11712878 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians' willingness to perform actions disallowed by the American Medical Association
Number of subjects: 1000
Study 11712878 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians' willingness to perform five or more disallowed actions
Number of subjects: 1000
Study 11712878 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with perceived duty to society
Number of subjects: 1000
Study 11712878 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with approval of the death penalty
Number of subjects: 1000
Study 11712878 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with approval of assisted suicide
Number of subjects: 1000
Study 11712878 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of guidelines on physician participation in capital punishment
Number of subjects: 1000
Study 9486881 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic exploration
Number of subjects: 18
Study 9486881 — intervention group
Group type: COMPARATOR
Intervention: Traditional exploration
Number of subjects: 18
Study 7528299 — intervention group
Group type: EXPERIMENTAL
Intervention: nitrendipine (10‐20 mg b.i.d.)
Number of subjects: 48
Study 7528299 — intervention group
Group type: EXPERIMENTAL
Intervention: captopril (25‐50 mg b.i.d.)
Number of subjects: 48
Study 3053569 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiramycin tablets for 5 1/2 days
Number of subjects: 221
Study 3053569 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline tablets for nine days
Number of subjects: 221
Study 30111495 — intervention group
Group type: EXPERIMENTAL
Intervention: Active commercial breaks (ACBs) - prolonged sitting interrupted every 20 min with 3 min of light-intensity body-weight resistance activities
Number of subjects: 9
Study 30111495 — intervention group
Group type: COMPARATOR
Intervention: SIT - prolonged sitting during TV viewing
Number of subjects: 9
Study 30111495 — intervention group
Group type: EXPERIMENTAL
Intervention: Active commercial breaks (ACBs)
Number of subjects: 9
Study 30111495 — intervention group
Group type: COMPARATOR
Intervention: SIT
Number of subjects: 9
Study 28072987 — intervention group
Group type: EXPERIMENTAL
Intervention: Monolithic lithium disilicate (LS2) crown produced by CEREC (CER group)
Number of subjects: 13
Study 28072987 — intervention group
Group type: COMPARATOR
Intervention: Manually fabricated resin crown utilizing conventional workflow (CONV group)
Number of subjects: 13
Study 28072987 — intervention group
Group type: EXPERIMENTAL
Intervention: CER group
Number of subjects: 13
Study 28072987 — intervention group
Group type: COMPARATOR
Intervention: CONV group
Number of subjects: 13
Study 28072987 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival rate
Number of subjects: 13
Study 28072987 — intervention group
Group type: EXPERIMENTAL
Intervention: Screw loosening
Number of subjects: 13
Study 24998770 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma rich in growth factors (PRGF)
Number of subjects: 60
Study 24998770 — intervention group
Group type: COMPARATOR
Intervention: Blood clot (Control)
Number of subjects: 60
Study 23742789 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenotification package
Number of subjects: 367
Study 23742789 — intervention group
Group type: COMPARATOR
Intervention: Direct questionnaire mailing
Number of subjects: 367
Study 21397253 — intervention group
Group type: EXPERIMENTAL
Intervention: Active HF-rTMS (n = 22)
Number of subjects: 44
Study 21397253 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (n = 22)
Number of subjects: 44
Study 19632716 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent induction chemotherapy (two cycles of cisplatin [50 mg/m(2) on days 1, 8, 29, and 36] and etoposide [50 mg/m(2) on days 1‐5 and 29‐33]) plus radiotherapy (45 Gy) followed by surgical resection if no progression.
Number of subjects: 396
Study 19632716 — intervention group
Group type: COMPARATOR
Intervention: Standard concurrent chemotherapy and definitive radiotherapy without resection (up to 61 Gy).
Number of subjects: 396
Study 19632716 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent induction chemotherapy plus radiotherapy followed by surgical resection.
Number of subjects: 396
Study 19632716 — intervention group
Group type: COMPARATOR
Intervention: Standard concurrent chemotherapy and definitive radiotherapy without resection.
Number of subjects: 396
Study 16541859 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture kinetotherapy (Acupuncture at Kaiyin point No. 1 combined with deep respiratory movement of the glottis), once daily for 5 days
Number of subjects: 80
Study 16541859 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic aerosol inhalation of 0.9% sodium chloride injection, gentamicin sulfate injection 80,000 U and Dexamethasone injection 5mg, twice a day for 5 days
Number of subjects: 80
Study 15553817 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuxuetong (SXT)
Number of subjects: 68
Study 15553817 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 68
Study 11091827 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar electrodissection technique
Number of subjects: 70
Study 11091827 — intervention group
Group type: COMPARATOR
Intervention: Dissection ligation technique
Number of subjects: 70
Study 11091827 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 70
Study 9075040 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous clonidine 3 micrograms/kg
Number of subjects: 33
Study 9075040 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clonidine 4 micrograms/kg
Number of subjects: 33
Study 9075040 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 1783695 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide sedation
Number of subjects: 56
Study 1783695 — intervention group
Group type: COMPARATOR
Intervention: Behavioral management only (control)
Number of subjects: 56
Study 7050341 — intervention group
Group type: EXPERIMENTAL
Intervention: Johnson and Johnson unwaxed dental floss
Number of subjects: 80
Study 7050341 — intervention group
Group type: EXPERIMENTAL
Intervention: Waxed dental floss
Number of subjects: 80
Study 7050341 — intervention group
Group type: COMPARATOR
Intervention: Control group (other types of dental floss)
Number of subjects: 80
Study 31653518 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-phosphorus diet
Number of subjects: 8